Monica Colvin is a Cardiology physician affiliated with University of Michigan. OpenAlex indexes 230 publications with 21,924 citations (h-index 57); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Severe CAV MRI in Heart Transplant Recipient
Sponsor: University of Minnesota
- Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients
Sponsor: University of Minnesota
- Noninvasive Predictors of Transplant Vasculopathy
Sponsor: University of Minnesota
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.9%Beta blocker15.1%Metoprolol Succinate58%Carvedilol32%Bisoprolol Fumarate10%Part D<11 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)12.8%Entresto100%Part D≥44 patients+ 10 more classes in this area
Metabolism & gastrointestinal
12.2%SGLT2 inhibitor5.4%Jardiance60%Farxiga40%Part D<11 patientsPotassium supplement3.1%Potassium Chloride100%Part D≥17 patients+ 2 more classes in this area
Cancer & immunology
5.4%Calcineurin inhibitor4.4%Tacrolimus100%Part D<11 patientsKinase inhibitor1.1%Sirolimus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”